Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial
Abstract
OBJECTIVE: Retrospective studies have indicated that anti-thyroid drugs (ATD) might possess a radioprotective effect, leading to a higher rate of recurrence of hyperthyroidism after iodine-131 ((131)I) therapy. DESIGN: A randomized clinical trial was performed to clarify whether resumption of methimazole after (131)I influences the final outcome of this treatment. METHODS: We assigned 149 patients with Graves' disease or a toxic nodular goitre to groups either to resume (+ATD) or not to resume (-ATD) methimazole 7 days after (131)I. Before (131)I therapy, all patients were rendered euthyroid by methimazole, which was discontinued 4 days before the (131)I therapy. RESULTS: During the follow-up period of 12 Months, 13 patients developed hypothyroidism, 42 were euthyroid, and 18 had recurrence of hyperthyroidism in the +ATD group; the respective numbers in the -ATD group were 16, 42 and 18 (P=0.88). At 3 weeks after (131)I therapy, the serum free-thyroxine index was slightly decreased (by 5.7%; 95% confidence interval (CI) -15.5 to 5.4%) in the +ATD group, in contrast to an increase of 35.9% (95% CI 18.8 to 55.5%) in the -ATD group (P<0.001 between groups). In the subgroup that remained euthyroid during follow-up, thyroid Volume reduction, assessed by ultrasonography, was smaller in the +ATD group [38.7% (95% CI 33.3 to 44.1%)] than in the -ATD group [48.6% (95% CI: 41.5-55.6%)] (P<0.05). CONCLUSION: No radioprotective effect could be demonstrated, with regard to final thyroid function, for the resumpton of methimazole 7 days after (131)I therapy. Although resumption of methimazole slightly reduced the magnitude of shrinkage of the goitre obtained by (131)I, the prevention of a temporary thyrotoxicosis in the early period after radiation favours this regimen.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In one study, if MMI was restarted 7 days after RAI, free T4 measured 3 weeks after RAI was 6% lower than at the time of RAI administration; if MMI was not restarted, free T4 values were 36% higher.
“In one study, if MMI was restarted 7 days after RAI, the free T 4 measured 3 weeks after RAI was 6% lower than the values at the time of RAI administration, and if MMI was not restarted after RAI, the free T 4 values were 36% higher than the values at the time of RAI administration (80).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [80]
Some physicians restart ATDs after treatment with RAI, but this practice is seldom required in children.
“Although some physicians restart ATDs after treatment with RAI (80), this practice is seldom required in children (309,310,350).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [80]
Cites
Current Trends in the Management of Graves' Disease*
Solomon, B. L., Glinoer, D., Lagasse, R., & Wartofsky, L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1518 · Cited by 266 · see citing works
Radioiodine Treatment of Hyperthyroidism--Prognostic Factors for Outcome
Allahabadia, A., Daykin, J., Sheppard, M. C., Gough, S. C. L., & Franklyn, J. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7781 · Cited by 265 · see citing works
A Randomized Comparison of Radioiodine Doses in Graves’ Hyperthyroidism
Leslie, W. D., Ward, L., Salamon, E. A., Ludwig, S., Rowe, R. C., & Cowden, E. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020805 · Cited by 204 · see citing works
High Dose131I Therapy for the Treatment of Hyperthyroidism Caused by Graves’ Disease
Alexander, E. K., & Larsen, P. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8333 · Cited by 191 · see citing works
Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
Jarløv, A. E., Hegedüst, L., Kristensen, L. Ø., Nygaard, B., & Hansen, J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02039.x · Cited by 155 · see citing works
Nygaard, B., Hegedüs, L., Gerhard Nielsen, K., Ulriksen, P., & Hansen, J. M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00635.x · Cited by 148 · see citing works
Imseis, R. E., VanMiddlesworth, L., MASSIE, J. D., Bush, A. J., & Vanmiddlesworth, N. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4538 · Cited by 147 · see citing works
Andrade, V. A., Gross, J. L., & Maia, A. L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7707 · Cited by 143 · see citing works
Procedure guideline for therapy of thyroid disease with (131)iodine.
Meier, D. A., Brill, D., Becker, D. V., Clarke, S. E., Silberstein, E. B., Royal, H. D., & Balon, H. R. (2002) · PubMed · Cited by 134 · see citing works
Success Rate of Radioiodine Therapy in Graves' Disease: The Influence of Thyrostatic Medication
Sabri, O., Zimny, M., Schulz, G., Schreckenberger, M., Reinartz, P., Willmes, K., & Buell, U. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5588 · Cited by 129 · see citing works
Radioiodine Therapy for Multinodular Toxic Goiter
Nygaard, B., Hegedüs, L., Ulriksen, P., Nielsen, K. G., & Hansen, J. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.12.1364 · Cited by 120 · see citing works
Tuttle, R. M., Patience, T. H., & BUDD, S. (1995) · Thyroid · doi:10.1089/thy.1995.5.243 · Cited by 104 · see citing works
Braga, M., Walpert, N., Burch, H. B., Solomon, B. L., & Cooper, D. S. (2002) · Thyroid · doi:10.1089/105072502753522365 · Cited by 96 · see citing works
The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease
Hancock, L. D., Tuttle, R. M., LeMar, H. J., Bauman, J. W., & Patience, T. H. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2741075.x · Cited by 92 · see citing works
Nygaard, B., Knudsen, J. H., Hegedűs, L. D., Veje, A., & Hansen, J. E. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4227 · Cited by 92 · see citing works
Self-citationMarcocci, C., Gianchecchi, D., Masini, I., Golia, F., Ceccarelli, C., Bracci, E., Fenzi, G., & Pinchera, A. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03348615 · Cited by 89 · see citing works
Catargi, B., Leprat, F., Guyot, M., Valli, N., Ducassou, D., & Tabarin, A. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410117 · Cited by 89 · see citing works
Burch, H. B., Solomon, B. L., Cooper, D. S., Ferguson, P., Walpert, N., & Howard, R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7639 · Cited by 85 · see citing works
Thyroid size determined by ultrasound. Influence of physiological factors and non-thyroidal disease.
Hegedüs, L. (1990) · PubMed · Cited by 84 · see citing works
Effect of Pretreatment with Methylthiouracil on Results of 131I Therapy
Crooks, J., Buchanan, W. W., Wayne, E. J., & Macdonald, E. (1960) · BMJ · doi:10.1136/bmj.1.5167.151 · Cited by 74 · see citing works
Nygaard, B., Hegedűs, L. D., Gervil, M., Hjalgrim, H., HANSEN, B. M., Søe‐Jensen, P., & Hansen, J. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01230.x · Cited by 64 · see citing works
Howarth, D. M., Epstein, M. T., Lan, L., Tan, P., & Booker, J. A. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590100621 · Cited by 62 · see citing works
Velkeniers, B. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91950-2 · Cited by 56 · see citing works
Andrade, V. A., Gross, J. L., & Maia, A. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6149 · Cited by 53 · see citing works
Ahmad, A., Ahmad, M., & Young, E. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460767 · Cited by 51 · see citing works
Antithyroid drugs and radioactive iodine. Fifteen years' experience with Graves' disease
Reynolds, L. R. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.139.6.651 · Cited by 47 · see citing works
Körber, C., Schneider, P. F., Körber-Hafner, N., Hänscheid, H., & Reiners, C. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590100565 · Cited by 44 · see citing works
Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils
Imamura, M., Aoki, N., Saito, T., Ohno, Y., Maruyama, Y., Yamaguchi, J., & Yamamoto, T. (1986) · European Journal of Endocrinology · doi:10.1530/acta.0.1120210 · Cited by 44 · see citing works
Kok, S. W., Smit, J. W. A., de Craen, A. J. M., Goslings, B. M., van Eck‐Smit, B. L. F., & Romijn, J. A. (2000) · Nuclear Medicine Communications · doi:10.1097/00006231-200011000-00014 · Cited by 39 · see citing works
Kung, A. W. C., Yau, C.-C., & Cheng, A. C. K. (1995) · Thyroid · doi:10.1089/thy.1995.5.7 · Cited by 36 · see citing works
Clerc, J., Izembart, M., Dagousset, F., Jaïs, J., Heshmati, H. M., Chevalier, A., Léger, A., & Barritault, L. (1993) · PubMed · Cited by 36 · see citing works
Iodine-131 uptake and turnover rate vary over short intervals in Gravesʼ disease
van Isselt, J. W., de Klerk, J. M. H., Koppeschaar, H. P. F., & van Rijk, P. P. (2000) · Nuclear Medicine Communications · doi:10.1097/00006231-200007000-00002 · Cited by 36 · see citing works
Nakazato, N., Yoshida, K., Mori, K., KISO, Y., SAYAMA, N., Tani, J., Nakagawa, Y., & Ito, S. (1999) · Thyroid · doi:10.1089/thy.1999.9.775 · Cited by 20 · see citing works
Turton, D. B., SILVERMAN, E. D., & Shakir, K. M. M. (1998) · Clinical Nuclear Medicine · doi:10.1097/00003072-199812000-00004 · Cited by 16 · see citing works
Connell, J. M. C., Hilditch, T. E., Robertson, J., Coghill, G., & Alexander, W. D. (1987) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00252995 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
“In one study, if MMI was restarted 7 days after RAI, the free T4 measured 3 weeks after RAI was 6% lower than the values at the time of RAI administration, and if MMI was not restarted after RAI, the free T4 values were 36% higher than the values at the time of RAI administration (80).”
BackgroundBahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098 · see citing works
2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K. G., & Pearce, S. H. S. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 982 · see citing works
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898 · see citing works
Bonnema, S. J., & Hegedűs, L. D. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1030 · Cited by 338 · see citing works
Self-citationDiagnosis and management of Graves disease: a global overview
Bartalena, L. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.193 · Cited by 299 · see citing works
Franklyn, J. A., & Boelaert, K. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60782-4 · Cited by 262 · see citing works
Antithyroid drug therapy: 70 years later
Burch, H. B., & Cooper, D. S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0678 · Cited by 124 · see citing works
Radioiodine treatment for benign thyroid diseases
Weetman, A. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02841.x · Cited by 90 · see citing works
Bonnema, S. J., Bennedbæk, F. N., Veje, A., Marving, J., & Hegedűs, L. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0247 · Cited by 90 · see citing works
Self-citationBogazzi, F., Giovannetti, C., Fessehatsion, R., Tanda, M. L., Campomori, A., Compri, E., Rossi, G., Ceccarelli, C., Vitti, P., Pinchera, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1655 · Cited by 88 · see citing works
Treatment of Graves' Hyperthyroidism: Evidence-Based and Emerging Modalities
Hegedűs, L. D. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.01.009 · Cited by 76 · see citing works
Approach to Management of the Patient with Primary or Secondary Intrathoracic Goiter
Hegedűs, L. D., & Bonnema, S. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1638 · Cited by 57 · see citing works
Self-citationGuidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016
Minamitani, K., Sato, H., Ohye, H., Harada, S., & Arisaka, O. (2017) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.26.29 · Cited by 54 · see citing works
Medical Treatment of Hyperthyroidism: State of the Art
Fumarola, A., Fiore, A. D., Dainelli, M., Grani, G., & Calvanese, A. (2010) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0030-1253420 · Cited by 51 · see citing works
Bonnema, S. J., Bennedbæk, F. N., Veje, A., Marving, J., & Hegedűs, L. D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0226 · Cited by 51 · see citing works
Self-citationMaia, A. L., Scheffel, R. S., Meyer, E. L. D. S., Mazeto, G. M. F. D. S., de Carvalho, G. A., Graf, H., Vaisman, M., Maciel, L. M. Z., Ramos, H. E., Tincani, Á. J., et al. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000300006 · Cited by 58 · see citing works
Glucocorticoids do not influence the effect of radioiodine therapy in Graves’ disease
Jensen, B. E. S., Bonnema, S. J., & Hegedűs, L. D. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01924 · Cited by 42 · see citing works
Self-citationCurrent and Future Treatments for Graves’ Disease and Graves’ Ophthalmopathy
Kotwal, A., & Stan, M. N. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0739-8134 · Cited by 40 · see citing works
Treating the thyroid in the presence of Graves’ ophthalmopathy
Hegedűs, L. D., Bonnema, S. J., Smith, T. J., & Brix, T. H. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.09.005 · Cited by 37 · see citing works
Self-citationThe role of radioiodine therapy in benign nodular goitre
Bonnema, S. J., Fast, S., & Hegedűs, L. D. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.02.001 · Cited by 30 · see citing works
Self-citationThiamazole as an adjuvant to radioiodine for volume reduction of multinodular goiter
Albino, C. C., Graf, H., Sampaio, A. P., Vigário, A., & Paz-Filho, G. J. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802501325 · Cited by 24 · see citing works
Bonnema, S. J., Fast, S., & Hegedűs, L. D. (2011) · Endocrine · doi:10.1007/s12020-011-9542-6 · Cited by 20 · see citing works
Self-citationA randomized trial evaluating a block-replacement regimen during radioiodine therapy
Bonnema, S. J., Grupe, P., Boel-Jørgensen, H., Brix, T. H., & Hegedűs, L. D. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02452.x · Cited by 9 · see citing works
Self-citationFadeev, V. V. (2020) · Clinical and experimental thyroidology · doi:10.14341/ket12474 · Cited by 8 · see citing works
Radioiodine in the Management of Benign Thyroid Disease
Ahmad, S., & Shirazi, N. (2018) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/13094_29 · Cited by 7 · see citing works
Radioiodine Treatment in Patients with Graves’ Disease
Ross, D. S. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2534-6_7 · Cited by 6 · see citing works
Severe radiation thyroiditis after radioactive iodine for treatment of Graves’ disease
Tay, W., Lee, L., Tong, A., & Chng, C. L. (2020) · Singapore Medical Journal · doi:10.11622/smedj.2020039 · Cited by 5 · see citing works
Mazzaferri, E. L. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70357-3 · Cited by 4 · see citing works
Mazzaferri, E. L. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70613-8 · Cited by 3 · see citing works
Aktolun, C., & Urhan, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4021-5_17 · Cited by 3 · see citing works
Risk factors and clinical characteristics associated with post-radioactive iodine thyroid storm
Chiu, H. H. C., Hernandez, E. F., Magnaye, F. M., Sahagun, J. A. R., Sarsagat, J. P. D., & Wang, J. (2024) · Thyroid Research · doi:10.1186/s13044-024-00217-4 · Cited by 2 · see citing works
Hegedűs, L. D., Paschke, R., Krohn, K., & Bonnema, S. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00090-1 · Cited by 2 · see citing works
Self-citationDocrat, F., Mokoena, T., KARUSSEIT, V. O. L., & Ankrah, A. O. (2021) · South African Medical Journal · doi:10.7196/samj.2021.v111i2.14522 · Cited by 2 · see citing works
Antithyroid Drug Therapy in Patients with Graves’ Disease
Laurberg, P., & Cooper, D. S. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2534-6_6 · Cited by 2 · see citing works
Hegedűs, L. D., Paschke, R., Krohn, K., & Bonnema, S. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00087-3 · Cited by 2 · see citing works
Self-citationRadioiodine Therapy of Hyperthyroidism in Graves’ Disease
Wong, W. Y., & Goh, A. S. W. (2012) · Medical radiology · doi:10.1007/174_2012_674 · Cited by 2 · see citing works
The relationship between thyroid eye disease and radioiodine treatment
Thou, S., & Vinjamuri, S. (2019) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000965 · Cited by 2 · see citing works
Hollander, J. M., & Davies, T. F. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4745-2.00012-2 · Cited by 1 · see citing works
Bonnema, S. J., & Hegedűs, L. D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2189 · Cited by 1 · see citing works
Self-citationBest Practice & Research Clinical Endocrinology & Metabolism
der Grinten, H. L. C., Otten, B. J., Stikkelbroeck, M., Sweep, F. C. G. J., & Hermus, A. R. M. M. (2009)
Mbachu, N. A., Afolabi, A. O., & Anetor, J. I. (2016)
Bartalena, L. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_17
Bartalena, L. (2016) · Endocrinology · doi:10.1007/978-3-319-29195-6_17-1
Mirjalili, S. R., Razmpoosh, E., Eshraghi, R., Ashoori, M., & Soltani, S. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf580 · Cited by 1 · see citing works
A systematic review and meta-analysis of treatment outcome after I-131 for solitary toxic adenoma
van der Meeren, M. M. D., Roerink, S. H. P. P., Konings, M., Wever, K. E., Vriens, D., & Oyen, W. J. G. (2026) · The EANM Journal · doi:10.1016/j.eanmj.2026.100224
- Authors
- Bonnema, S., Bennedbaek, F., Gram, J., Veje, A., Marving, J., & Hegedus, L.
- Affiliations
- Odense University Hospital (DK)
- ORCID
- Gram, J
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-12-01
- Volume
- 149
- Issue
- 6
- Pages
- 485-492
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2103445173
- Cited by
- 47
- References
- 35
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 5 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 5
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- methimazole, iodine-131 therapy, hyperthyroidism, Graves' disease, toxic nodular goiter, antithyroid drugs, radioprotective effect, hypothyroidism, hyperthyroidism recurrence, thyroid volume, free thyroxine index, thyroid function, thyroid ultrasound
- MeSH terms
- Aged, Combined Modality Therapy, Female, Follow-Up Studies, Goiter, Nodular, Graves Disease, Humans, Iodine Radioisotopes, Male, Methimazole, Middle Aged, Radiation-Protective Agents, Recurrence, Antithyroid Agents, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review